Ascendis Pharma A ASND
NASDAQ ASND
$227.87 +0.56 (+0.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Depreciation and Depletion (2014 - 2026)

Updated

Ascendis Pharma A's Depreciation and Depletion was $5.31 million in the quarter ended Jun 30, 2026, up 8.9% from $4.88 million a year earlier and up 7.5% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Depreciation and Depletion (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ascendis Pharma A's Depreciation and Depletion was $19.99 million through Jun 30, 2026, up 5.3% year-over-year; for the year ended Dec 31, 2025, it came in at $19.44 million, up 4.1% from the prior year.

  • Depreciation and Depletion shows a five-year compound annual growth rate of 11.5% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Depreciation and Depletion was $18.67 million in the year ended Dec 31, 2024 (-6.4%), $19.93 million in the year ended Dec 31, 2023 (+8.0%), $18.46 million in the year ended Dec 31, 2022 (+8.0%) and $17.1 million in the year ended Dec 31, 2021 (+51.8%).
  • Quarterly Depreciation and Depletion has moved between $4.28 million (the quarter ended Sep 30, 2025) and $5.47 million (the quarter ended Dec 31, 2025) over five years.
  • Compared with a year earlier, Depreciation and Depletion has increased for three straight quarters, with growth averaging 1.3% over the last eight quarters.
  • The best year-over-year quarter for Depreciation and Depletion over five years was the quarter ended Sep 30, 2021 (growth of 63.3%); the worst was the quarter ended Dec 31, 2024 (a decline of 10.4%).
  • Per Business Quant data, ASND's Depreciation and Depletion in the three quarters before the quarter ended Jun 30, 2026 was $4.94 million (quarter ended Mar 31, 2026), $5.47 million (quarter ended Dec 31, 2025) and $4.28 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Ascendis Pharma A 14.09 Bn 10.33 Bn 362.22 Mn 5.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.31 Mn
Mar 31, 2026 4.94 Mn
Dec 31, 2025 5.47 Mn
Sep 30, 2025 4.28 Mn
Jun 30, 2025 4.88 Mn
Mar 31, 2025 4.78 Mn
Dec 31, 2024 4.65 Mn
Sep 30, 2024 4.68 Mn
Jun 30, 2024 4.60 Mn
Mar 31, 2024 4.74 Mn
Dec 31, 2023 5.19 Mn
Sep 30, 2023 5.04 Mn
Jun 30, 2023 4.94 Mn
Mar 31, 2023 4.76 Mn
Dec 31, 2022 4.62 Mn
Sep 30, 2022 4.44 Mn
Jun 30, 2022 4.57 Mn
Mar 31, 2022 4.83 Mn
Dec 31, 2021 4.76 Mn
Sep 30, 2021 4.33 Mn
API Access

Ascendis Pharma A Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ASND&period=max&api_key=YOUR_API_KEY